1. Please check and comment entries here.
Table of Contents

    Topic review

    Biological Clock in Liver Cancer

    View times: 5
    Submitted by: Gianluigi Mazzoccoli

    Definition

    The biological clock controls at the molecular level several aspects of mammalian physiology, by regulating daily oscillations of crucial biological processes such as nutrient metabolism in the liver. Disruption of the circadian clock circuitry has recently been identified as an independent risk factor for cancer and classified as a potential group 2A carcinogen to humans. Hepatocellular carcinoma (HCC) is the prevailing histological type of primary liver cancer, one of the most important causes of cancer-related death worldwide. HCC onset and progression is related to B and C viral hepatitis, alcoholic and especially non-alcoholic fatty liver disease (NAFLD)-related milieu of fibrosis, cirrhosis, and chronic inflammation.

    1. Introduction

    Worldwide, liver cancer ranks second among the principal causes of cancer-related death and fifth in men and ninth in women among the most commonly diagnosed cancers, respectively, with more than 800,000 new cases in 2018 and hepatocellular cancer (HCC) accounting for 70–85% of all liver cancers [1][2]. Recent availability of effective direct antiviral agents targeting hepatitis C virus (HCV) NS3/4A (protease), NS5B (polymerase), and NS5A (nonstructural) protein has greatly curtailed the causative role of HCV infection in hepatocarcinogenesis and the most important risk factor for liver cancer is actually represented by excess body fat. The global epidemics of obesity, metabolic syndrome, type 2 diabetes, and nonalcoholic fatty liver disease (NAFLD) facilitated the quick rise in HCC prevalence [3]. NAFLD may progress to nonalcoholic steato-hepatitis (NASH), hallmarked by steatosis with necroinflammation, and in due course to fibrosis, cirrhosis, and HCC. For HCC developing without cirrhosis, associated factors may include inflammatory, metabolic, endocrine, bile acid flux, and gut microbiome derangements associated with obesity and liver fat accumulation [3].

    2. The Circadian Clock Circuitry and the Molecular Mechanisms of Hepatocellular Carcinogenesis

    Hepatic carcinogenesis is linked to the ongoing failure of mechanisms managing basic cellular processes, such as cell cycle, proliferation, differentiation, apoptosis, DNA damage response, autophagy, xenobiotic detoxification, anabolic/catabolic processes, and oxidation-reduction reactions with reactive oxygen species production/antioxidant defenses balance [4]. Key embryogenesis-related and oncogenic pathways have been recognized by genetic studies as deranged as well, among which WNT/β-catenin, proliferation, and hepatoblastoma-like pathways, at present are not easily druggable for targeted cancer therapy [4]. The greater part of the aforementioned biological processes and signaling pathways are hallmarked by rhythmic activity fluctuations with about 24-h (circadian) periodicity [5][6][7].
    The nycthemeral rhythmicity featuring behavior (locomotor activity, eating/fasting, sleeping/waking) and physiology (temperature, blood pressure, hormone secretion) of living beings is controlled by the circadian timing system. This time-keeping system is organized as a hierarchical network comprising self-sufficient biological oscillators in the hypothalamic suprachiasmatic nuclei (SCN) and in peripheral tissues. The circadian timing system operates by transduction and integration of photic signaling (outdoor light levels/indoor lighting conditions) and grants organism/species survival advantage through appropriate anticipation of expected environmental changes. The central pacemaker (SCN) entrains peripheral tissues oscillators by means of cues, such as hormone (cortisol, melatonin), physical (temperature fluctuations), and neural (autonomic nervous system fibers) outputs. This complex and rhythmic signaling drives behavioral cycles (food craving and intake, rest-activity), nervous, cardio-vascular, gastro-intestinal, and musculoskeletal system function in synchrony with metabolic pathway activation, transcriptome-metabolome oscillations, oxidation-reduction reactions, and nutrient level fluctuations [5][6][7].
    At the cellular level 24-h rhythms are generated by a molecular mechanism maneuvering transcription-translation feedback loops hard-wired by intertwining circadian genes and proteins, precisely ARNTL/2 (BMAL1/2), CLOCK (or its paralog NPAS2), PERIOD (PER) 1–3, CRYPTOCHROME (CRY) 1–2, REV-ERBs/RORs nuclear receptors and TIMELESS. The transcription factors CLOCK and BMAL1 heterodimerize, bind to E-box enhancer elements in the promoters of the genes PER1-3 and CRY1-2 and turn on their transcription, whereas PER and CRY protein complexes impede their transcriptional activity [8]. TIMELESS intermingles with TIPIN and deals with DNA replication and damage response, above all S-phase arrest and signaling pathways mediated by ATR-Chk1 and ATM-Chk2 [9]. The nuclear receptors REV-ERB α/β (encoded by NR1D1/NR1D2) and ROR α/γ control ARNTL rhythmic transcription competing at ROR-responsive elements (RORE) of its promoter [10][11][12]. Post-translational modifications of circadian proteins, represented by phosphorylation, SUMOylation, acetylation and deacetylation, O-GlcNAcylation [13], hold up proper functioning of the molecular clockwork. In particular, phosphorylation is operated by several protein kinases, such as casein kinase (CK)1-ε (encoded by CSNK1Ε), adenosine monophosphate (AMP) activated kinase (AMPK), and glycogen synthase kinase (GSK)-3β [13][14]. In addition, ARNTL is SUMOylated with circadian rhythmicity in the mouse liver [15][16]. Acetylation is managed by histone/protein acetyl-transferases, such as CLOCK, while deacetylation is activated by histone/protein deacetylases, such as the NAD+-dependent SIRT1 [17][18][19][20]. The molecular clockwork drives the rhythmic transcription of clock controlled genes, such as the PAR bZIP transcription factors DBP, TEF, HLF, which in turn drive the expression of thousands of genes, among which are cell cycle progression regulators (Cyclin D1, Cyclin A, Mdm-2, c-Myc, WEE-1, GADD45Α) and tumor suppressor genes/oncogenes as well [21][22][23][24][25]. In pre-neoplastic liver lesions of Fischer 344 rats with induced carcinogenesis through the resistant hepatocyte model and in c-Myc/TGF-α transgenic mice, up-regulation of c-Myc, cyclin D1, cyclin A, and E2F1, involved in cyclin D1-CDK4, E2F1-DP1 complexes and pRb hyper-phosphorilation was identified [26][27]. Changes of G1 to S cell cycle phase transition ensuing from these derangements take part in human HCC, as well [28]. A proper functioning of the biological clock demonstrates tumor suppressing potential, whereas circadian rhythmicity disturbance, like that provoked by shift work in humans and chronic jet lag (CJL) in animal models, is an independent risk factor for HCC: for instance, it worked as tumor promoter in mice exposed to the hepatic carcinogen diethylnitrosamine (DEN) in combination with 8-h advance of light onset every 2 days [29]. Accordingly, chronic circadian disruption and ablation of Steroid Receptor Coactivator-2 (SRC-2), a crucial metabolic transcriptional co-regulator in SCN and liver, altered behavioral activities and metabolic homeostasis in SRC-2(-/-) mice, leading to NAFLD, NASH, and HCC [30]. Furthermore, animal experiments performed in wild type and core clock genes mutated mice revealed an evident augment of early NAFLD onset with progression to NASH, fibrosis, and, in due course, HCC. The exploration of the molecular mechanisms revealed deregulation of liver metabolic genes enriching nuclear receptor-controlled cholesterol/bile acid and xenobiotic metabolism pathways and suggested a protective role for farnesoid X receptor (FXR) and a pro-tumorigenic role for constitutive androstane receptor (CAR) [31]. Interestingly, evaluation of circadian genes and protein expression in human HCC and matched non-tumor specimens showed reduced expression levels of PER1, PER2, PER3, CRY2 in HCC, with over-expression of the histone methyltransferase Enhancer of zeste homolog 2 (EZH2) and promoter methylation, but no genetic mutations [32][33], and experiments performed in vitro challenging the PLC/PRF/5 human HCC cell line with CoCl2 for 24 h at increasing concentration (50, 100, and 200 µΜ) to mimic an hypoxic environment showed an additional effect of hypoxia in circadian genes’ deregulation in expression of in HCC [34].

    3. The Biological Clock and Systemic Therapy in Hepatocellular Carcinoma

    The role of the biological clock in pharmaceutical intervention for the treatment of NAFLD and the effects of dietary habits changes, especially in relationship to time-of-day of food consumption, in the organism’s metabolic homeostasis and in the physiopathology of hepatic steatosis have been extensively and comprehensively described in a recent review [35], so here we will limit ourselves to mentioning some fundamental concepts regarding a potential role of meal timing and frequency scheduling in NAFLD-NASH-HCC progression. In the last two decades, numerous scientific studies have tried to clarify the role of the biological clock in the regulation of metabolic pathways, while little is known about the effects of metabolism intermediates on the functioning of the biological clock, especially in conditions of alterations of the metabolic homeostasis. For example, the restriction of nutritional intake to specific time windows, i.e., time restricted feeding (TRF), has direct effects on behavioral and physiological patterns and determines a response of the organism apt to anticipate the moment of possible food intake, a phenomenon called food anticipatory activity, whose regulatory centers and bio-molecular mechanisms are still poorly defined [36]. The effects of the temporal restriction of food intake are better known, especially in rodents when used as experimental models. Usually the fasting/feeding cycle corresponds temporally to the sleep/wake cycle, differing in the various animal species, which can be diurnal (active by day), nocturnal (active by night), or crepuscular (active especially during twilight, for example at dawn and sunset). When the availability of food is temporarily restricted and out of phase with the body’s natural cycles, the expression of circadian genes is also decoupled in the peripheral tissues with respect to the SCN, which will continue to be synchronized to the natural light/dark cycle. Furthermore, TRF was shown to have more favorable effects on physiological (weight, visceral fat), metabolic (glycemic levels, glucose tolerance), and hormonal (serum insulin and leptin levels) parameters with respect to ad libitum diet, even when the caloric intake was represented from a diet high in fat [37]. Another option is represented by intermittent/periodic fasting and fasting-mimicking diets, capable to bring on visceral fat decrease with no lean body mass change, hasten immune system renewal, hinder and partly undo bone mineral density loss, halt and reduce incidence of inflammatory diseases and cancer [38]. These data suggest the importance of the temporal characteristics of food intake as well as food abstinence or reduction in order to maintain an adequate energy balance, deriving from the equilibrium between energy intake and expenditure, which in turn corresponds to the sum of basal metabolism, energy expenditure for physical activity, and diet-induced thermogenesis [37][39][40][41][42][43][44]. As far as humans are concerned, the possibility of using time scheduled food intake, i.e., chrono-nutrition, as a therapeutic strategy in conditions of altered metabolism, such as obesity, metabolic syndrome, diabetes mellitus, liver steatosis, as well as NAFLD/NASH-related HCC is a recent proposal, even if knowledge on how timed feeding influences the circadian timing system and the molecular clockwork is still limited. Anyway, recent studies already suggest that the timing of nutrition could translate into a beneficial approach to improve weight loss and metabolic homeostasis in humans and support the possibility to combine timed feeding/fasting-associated interventions with standard therapeutic strategies for neoplastic diseases, liver cancer included, although the physiological mechanisms and molecular signaling pathways implicated in these favorable modifications need to be better defined [45].

    The entry is from 10.3390/cancers11111778

    References

    1. Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018, 68, 394–424.
    2. Akinyemiju, T.; Abera, S.; Ahmed, M.; Alam, N.; Alemayohu, M.A.; Allen, C.; Al-Raddadi, R.; Alvis-Guzman, N.; Amoako, Y.; Artaman, A.; et al. The Burden of Primary Liver Cancer and Underlying Etiologies from 1990 to 2015 at the Global, Regional, and National Level: Results from the Global Burden of Disease Study 2015. JAMA Oncol. 2017, 3, 1683–1691.
    3. Anstee, Q.M.; Reeves, H.L.; Kotsiliti, E.; Govaere, O.; Heikenwalder, M. From NASH to HCC: Current concepts and future challenges. Nat. Rev. Gastroenterol. Hepatol. 2019, 16, 411–428.
    4. Bruix, J.; Gores, G.J.; Mazzaferro, V. Hepatocellular carcinoma: Clinical frontiers and perspectives. Gut 2014, 63, 844–855.
    5. Albrecht, U. Timing to perfection: The biology of central and peripheral circadian clocks. Neuron 2012, 74, 246–260.
    6. Lowrey, P.L.; Takahashi, J.S. Genetics of circadian rhythms in Mammalian model organisms. Adv. Genet. 2011, 74, 175–230.
    7. Anderson, G.; Beischlag, T.V.; Vinciguerra, M.; Mazzoccoli, G. The circadian clock circuitry and the AHR signaling pathway in physiology and pathology. Biochem. Pharmacol. 2013, 85, 1405–1416.
    8. Takahashi, J.S. Transcriptional architecture of the mammalian circadian clock. Nat. Rev. Genet. 2017, 18, 164–179.
    9. Mazzoccoli, G.; Laukkanen, M.O.; Vinciguerra, M.; Colangelo, T.; Colantuoni, V. A Timeless Link between Circadian Patterns and Disease. Trends Mol. Med. 2016, 22, 68–81.
    10. Ripperger, J.A.; Albrecht, U. REV-ERB-erating nuclear receptor functions in circadian metabolism and physiology. Cell Res. 2012, 22, 1319–1321.
    11. Partch, C.L.; Green, C.B.; Takahashi, J.S. Molecular architecture of the mammalian circadian clock. Trends Cell Biol. 2014, 24, 90–99.
    12. Mohawk, J.A.; Green, C.B.; Takahashi, J.S. Central and peripheral circadian clocks in mammals. Annu. Rev. Neurosci. 2012, 35, 445–462.
    13. Koike, N.; Yoo, S.H.; Huang, H.C.; Kumar, V.; Lee, C.; Kim, T.K.; Takahashi, J.S. Transcriptional architecture and chromatin landscape of the core circadian clock in mammals. Science 2012, 338, 349–354.
    14. Sahar, S.; Zocchi, L.; Kinoshita, C.; Borrelli, E.; Sassone-Corsi, P. Regulation of BMAL1 protein stability and circadian function by GSK3beta-mediated phosphorylation. PLoS ONE 2010, 5, e8561.
    15. Cardone, L.; Hirayama, J.; Giordano, F.; Tamaru, T.; Palvimo, J.J.; Sassone-Corsi, P. Circadian clock control by SUMOylation of BMAL1. Science 2005, 309, 1390–1394.
    16. Lee, J.; Lee, Y.; Lee, M.J.; Park, E.; Kang, S.H.; Chung, C.H.; Lee, K.H.; Kim, K. Dual modification of BMAL1 by SUMO2/3 and ubiquitin promotes circadian activation of the CLOCK/BMAL1 complex. Mol. Cell. Biol. 2008, 28, 6056–6065.
    17. Nakahata, Y.; Kaluzova, M.; Grimaldi, B.; Sahar, S.; Hirayama, J.; Chen, D.; Guarente, L.P.; Sassone-Corsi, P. The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 2008, 134, 329–340.
    18. Nakahata, Y.; Sahar, S.; Astarita, G.; Kaluzova, M.; Sassone-Corsi, P. Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Science 2009, 324, 654–657.
    19. Asher, G.; Gatfield, D.; Stratmann, M.; Reinke, H.; Dibner, C.; Kreppel, F.; Mostoslavsky, R.; Alt, F.W.; Schibler, U. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 2008, 134, 317–328.
    20. Ramsey, K.M.; Yoshino, J.; Brace, C.S.; Abrassart, D.; Kobayashi, Y.; Marcheva, B.; Hong, H.K.; Chong, J.L.; Buhr, E.D.; Lee, C.; et al. Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis. Science 2009, 324, 651–654.
    21. Bozek, K.; Relogio, A.; Kielbasa, S.M.; Heine, M.; Dame, C.; Kramer, A.; Herzel, H. Regulation of clock-controlled genes in mammals. PLoS ONE 2009, 4, e4882.
    22. Hughes, M.E.; DiTacchio, L.; Hayes, K.R.; Vollmers, C.; Pulivarthy, S.; Baggs, J.E.; Panda, S.; Hogenesch, J.B. Harmonics of circadian gene transcription in mammals. PLoS Genet. 2009, 5, e1000442.
    23. Matsuo, T.; Yamaguchi, S.; Mitsui, S.; Emi, A.; Shimoda, F.; Okamura, H. Control mechanism of the circadian clock for timing of cell division in vivo. Science 2003, 302, 255–259.
    24. Hunt, T.; Sassone-Corsi, P. Riding tandem: Circadian clocks and the cell cycle. Cell 2007, 129, 461–464.
    25. Filipski, E.; King, V.M.; Li, X.; Granda, T.G.; Mormont, M.C.; Liu, X.; Claustrat, B.; Hastings, M.H.; Levi, F. Host circadian clock as a control point in tumor progression. J. Natl. Cancer Inst. 2002, 94, 690–697.
    26. Santoni-Rugiu, E.; Jensen, M.R.; Thorgeirsson, S.S. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha. Cancer Res. 1998, 58, 123–134.
    27. Pascale, R.M.; Simile, M.M.; De Miglio, M.R.; Muroni, M.R.; Calvisi, D.F.; Asara, G.; Casabona, D.; Frau, M.; Seddaiu, M.A.; Feo, F. Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis. Hepatology 2002, 35, 1341–1350.
    28. Greenbaum, L.E. Cell cycle regulation and hepatocarcinogenesis. Cancer Biol. Ther. 2004, 3, 1200–1207.
    29. Filipski, E.; Subramanian, P.; Carriere, J.; Guettier, C.; Barbason, H.; Levi, F. Circadian disruption accelerates liver carcinogenesis in mice. Mutat. Res. 2009, 680, 95–105.
    30. Fleet, T.; Stashi, E.; Zhu, B.; Rajapakshe, K.; Marcelo, K.L.; Kettner, N.M.; Gorman, B.K.; Coarfa, C.; Fu, L.; O'Malley, B.W.; et al. Genetic and Environmental Models of Circadian Disruption Link SRC-2 Function to Hepatic Pathology. J. Biol. Rhythm. 2016, 31, 443–460.
    31. Kettner, N.M.; Voicu, H.; Finegold, M.J.; Coarfa, C.; Sreekumar, A.; Putluri, N.; Katchy, C.A.; Lee, C.; Moore, D.D.; Fu, L. Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis. Cancer Cell 2016, 30, 909–924.
    32. Lin, Y.M.; Chang, J.H.; Yeh, K.T.; Yang, M.Y.; Liu, T.C.; Lin, S.F.; Su, W.W.; Chang, J.G. Disturbance of circadian gene expression in hepatocellular carcinoma. Mol. Carcinog. 2008, 47, 925–933.
    33. Yang, S.L.; Yu, C.; Jiang, J.X.; Liu, L.P.; Fang, X.; Wu, C. Hepatitis B virus X protein disrupts the balance of the expression of circadian rhythm genes in hepatocellular carcinoma. Oncol. Lett. 2014, 8, 2715–2720.
    34. Yu, C.; Yang, S.L.; Fang, X.; Jiang, J.X.; Sun, C.Y.; Huang, T. Hypoxia disrupts the expression levels of circadian rhythm genes in hepatocellular carcinoma. Mol. Med. Rep. 2015, 11, 4002–4008.
    35. Mazzoccoli, G.; De Cosmo, S.; Mazza, T. The Biological Clock: A Pivotal Hub in Non-alcoholic Fatty Liver Disease Pathogenesis. Front. Physiol. 2018, 9, 193.
    36. Acosta-Rodriguez, V.A.; de Groot, M.H.M.; Rijo-Ferreira, F.; Green, C.B.; Takahashi, J.S. Mice under Caloric Restriction Self-Impose a Temporal Restriction of Food Intake as Revealed by an Automated Feeder System. Cell Metab. 2017, 26, 267–277 e2.
    37. Chaix, A.; Zarrinpar, A.; Miu, P.; Panda, S. Time-restricted feeding is a preventative and therapeutic intervention against diverse nutritional challenges. Cell Metab. 2014, 20, 991–1005.
    38. Longo, V.D.; Panda, S. Fasting, Circadian Rhythms, and Time-Restricted Feeding in Healthy Lifespan. Cell Metab. 2016, 23, 1048–1059.
    39. Asher, G.; Sassone-Corsi, P. Time for food: The intimate interplay between nutrition, metabolism, and the circadian clock. Cell 2015, 161, 84–92.
    40. Sherman, H.; Genzer, Y.; Cohen, R.; Chapnik, N.; Madar, Z.; Froy, O. Timed high-fat diet resets circadian metabolism and prevents obesity. FASEB J. 2012, 26, 3493–3502.
    41. Jakubowicz, D.; Barnea, M.; Wainstein, J.; Froy, O. High caloric intake at breakfast vs. dinner differentially influences weight loss of overweight and obese women. Obesity 2013, 21, 2504–2512.
    42. Jakubowicz, D.; Wainstein, J.; Ahren, B.; Bar-Dayan, Y.; Landau, Z.; Rabinovitz, H.R.; Froy, O. High-energy breakfast with low-energy dinner decreases overall daily hyperglycaemia in type 2 diabetic patients: A randomised clinical trial. Diabetologia 2015, 58, 912–919.
    43. Garaulet, M.; Gomez-Abellan, P.; Alburquerque-Bejar, J.J.; Lee, Y.C.; Ordovas, J.M.; Scheer, F.A. Timing of food intake predicts weight loss effectiveness. Int. J. Obes. 2013, 37, 604–611.
    44. Morris, C.J.; Garcia, J.I.; Myers, S.; Yang, J.N.; Trienekens, N.; Scheer, F.A. The Human Circadian System Has a Dominating Role in Causing the Morning/Evening Difference in Diet-Induced Thermogenesis. Obesity 2015, 23, 2053–2058.
    45. Johnston, J.D.; Ordovas, J.M.; Scheer, F.A.; Turek, F.W. Circadian Rhythms, Metabolism, and Chrononutrition in Rodents and Humans. Adv. Nutr. 2016, 7, 399–406.
    More